ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1233

Epidemiology of GCA in Bergen (Western Norway) 1972-2012

Lene K Brekke1, Andreas P Diamantopoulos2, Elisabet L Esperø1, Bjørg-Tilde Fevang3,4, Johan G Brun3,4 and Clara G Gjesdal3,4, 1Haugesund Hospital for Rheumatic Diseases, Haugesund, Norway, 2Rheumatology, Haugesund Hospital for Rheumatic Diseases, Haugesund, Norway, 3Department of Rheumatology, Haukeland University Hospital, Bergen, Norway, 4Department of Clinical Science, University of Bergen, Bergen, Norway

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: giant cell arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Epidemiology and Public Health Poster II: Pathogenesis and Treatment of Systemic Inflammatory Diseases

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Giant cell arteritis (GCA) is the
most common systemic vasculitis in persons older than 50 years. The highest
incidence rates of the disease have been reported in the Scandinavian
countries. However, the epidemiology is changing as the elderly population is
increasing. The aim of this study was to investigate the epidemiology of GCA in
an expected high-incidence region over time. 

Methods:

This is a
retrospective cohort study of patients diagnosed with GCA in the hospitals of
Bergen Health Area (Helse Bergen) during 1972-2012. The International
Classification of Diseases (ICD)-coding system was used to identify patients
from hospital records, ICD-8 (446.4) for 1972-1987, ICD-9 (446.5) for 1987-1998
and ICD-10 (M31.5-6) for 1999-2012. The diagnosis was verified according to ACR
classification criteria by review of patient charts. The 820 patients who
satisfied these criteria were selected for initial analyses. Long term patient
outcomes were documented by review of patient charts from time of diagnosis
until time of death or end of study (31 Dec 2012). Information on time and
cause of death was collected from the Norwegian Cause of Death Registry. Incidence was calculated by using population
data for Hordaland County from Statistics Norway.

Results:

 

Among 820 identified GCA patients
there were 585 females (mean age 73.4 years, SD 8) and 235 males (mean age
71.7, SD 9). Five-hundred twenty-eight patients (64 %) had a positive temporal
artery biopsy and 206 patients (25 %) had a negative biopsy. For the remaining
86 patients (11 %) biopsy was not performed or biopsy results were
inconclusively or insufficiently reported. Patient characteristics and outcomes are presented in table 1.

The average annual incidence rate
for GCA was 15.7 per 100 000 > 50 years (females 20.4 and males 9.9). There were large
fluctuations in incidence according to year of diagnosis with a tendency of
progressive increase. The highest annual incidence rate observed was 35.1 in 2007. The lowest annual incidence rate was 2.6 in 1976 and 1978. Yearly distribution of
incidence rates is displayed in figure 1.

Four-hundred forty-three patients
(54 %) of our cohort died during the follow-up period.

 

Conclusion:

An increasing cumulative incidence
throughout the period 1972-2012 was observed in our study. Higher awareness of
GCA among clinicians could be an explanation. This interesting finding warrants
further investigation. 

 

Table 1. Patient characteristics and outcomes

 

 

Overall

n=820

Female

n=585

Male

n=236

Mean age at onset of GCA (SD)

 

72.9 (8.7)

73.4 (8.4)

71.7 (9.3)

 

 

 

 

 

ACR criteria fulfilled (%)

 

820 (100)

 

 

     Age ≥ 50 at disease onset (%)

 

816 (99.5)

583 (99.7)

233 (99.1)

     New onset headache (%)

 

592 (72.2)

418 (71.5)

174 (74.0)

     Temporal artery tenderness (%)

 

378 (46.1)

265 (45.3)

113 (48.1)

     Decreased temporal pulse(%)

 

230 (28)

170 (29.1)

60 (25.5)

     ESR ≥ 50 (%)

 

740 (90.2)

525 (89.7)

215 (91.5)

     Biopsy showing vasculitis (%)

 

528(64.4)

378 (64.6)

150 (63.8)

Giant cells in biopsy (%)

 

243 (29.6)

185 (31.6)

58 (24.7)

 

 

 

 

 

Mean ESR (SD) n=810

 

84.1 (27.6)

83.7 (27.9)

85.1 (27.0)

Mean CRP (SD) n=626

 

90.3 (63.4)

87.5 (62.3)

97.7 (65.2)

 

 

 

 

 

Jaw claudication (%)

 

181 (22.1)

134 (22.9)

47 (20)

Polymyalgia Rheumatica (%)

 

246 (30)

195 (33.3)

51 (21.7)

Peripheral Arthritis (%)

 

35 (4.3)

25 (4.3)

10 (4.3)

Visual disturbance (%)

 

149 (18.2)

106 (18.1)

43 (18.3)

     Blindness one or both eyes (%)

 

33 (4)

24 (4.1)

9 (3.8)

Scalp necrosis (%)

 

6 (0.7)

4 (0.7)

2 (0.9)

 

 

 

 

 

Number of deaths 1972-2012 (%)

 

443 (54)

311 (53.2)

132 (56.2)

 

 

 

 

 

Figure 1: Annual
incidence rate of GCA
per 100 000 persons age > 50
years


Disclosure: L. K. Brekke, None; A. P. Diamantopoulos, None; E. L. Esperø, None; B. T. Fevang, None; J. G. Brun, None; C. G. Gjesdal, None.

To cite this abstract in AMA style:

Brekke LK, Diamantopoulos AP, Esperø EL, Fevang BT, Brun JG, Gjesdal CG. Epidemiology of GCA in Bergen (Western Norway) 1972-2012 [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/epidemiology-of-gca-in-bergen-western-norway-1972-2012/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidemiology-of-gca-in-bergen-western-norway-1972-2012/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology